CytoDyn Inc (OTCQB:CYDY) CEO Nader Pourhassan tells Proactive it has completed an additional potentially non-dilutive convertible debt offering with an institutional investor, which provides $25 million of immediately available capital. Earlier this month, the company completed a similar convertible debt offering, also worth $25 million. Pourhassan talked through how the group will use the $50M, focusing on three key indications: COVID-19, HIV, and oncology.
CytoDyn CEO talks through its two recent convertible debt financing efforts of $50M
Quick facts: CytoDyn Inc.
Price: 2.32 USD
Market Cap: $1.47 billion
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...FOR OUR FULL DISCLAIMER CLICK HERE